4 completed. .
Follow Amoneta Diagnostics SAS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease Alzheimer Disease, Dementia | Completed | Amoneta Diagnostics SAS | 200 | 2019-10-28 | 2025-12-19 | |
| A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease Alzheimer's Disease (AD), Neurodegenerative Disease | Completed | Amoneta Diagnostics SAS | 150 | 2017-03-23 | 2025-12-29 | |
| ADDIA Chronobiological Study volumeric MRI - Alzheimer Disease | Completed | Amoneta Diagnostics SAS | 24 | 2016-11-01 | 2024-09-19 | |
| ADDIA Proof-of-Performance Clinical Study volumetric MRI - Alzheimer Disease (AD), Frontotemporal Lobar Degeneration | Completed | Amoneta Diagnostics SAS | 821 | 2016-09-01 | 2024-09-19 |
Alzheimer Disease (4) · Dementia (2) · Neurodegenerative Diseases (2) · Plaque, Amyloid (2) · Cognitive Dysfunction (1) · Corticobasal Degeneration (1) · Disease (1) · Frontotemporal Dementia (1) · Frontotemporal Lobar Degeneration (1) · Lewy Body Disease (1) · Memory Disorders (1) · Nerve Degeneration (1) · Supranuclear Palsy, Progressive (1)
France (3) · Switzerland (2) · Belgium (1) · Italy (1) · Turkey (Türkiye) (1)
Adrian Ivanoiu, MD (1) · Audrey Gabelle, MD (1) · Bruno Dubois, MD (1) · Catherine Mutter, MD (1) · Eloi Magnin, MD (1) · Florence Pasquier, MD (1) · Frisoni Giovanni, MD (1) · Hakan Gurvit, MD (1) · Jean-Christophe Bier, MD (1) · Moira Marizzoni, PhD (1) · Renaud David, MD (1)
2017 (1)